Cargando…

C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients

BACKGROUND: Serum C-reactive protein (CRP) is a biomarker of an acute inflammatory response and has been successfully used as a prognostic predictor for several malignancies. However, the clinicopathological significance of CRP levels in hepatocellular carcinoma (HCC) patients being treated with PD-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yiyang, Lu, Lianghe, He, Zhangping, Xu, Zhishen, Xiang, Zhicheng, Nie, Run-Cong, Lin, Wenping, Chen, Wenxu, Zhou, Jie, Yin, Yixin, Xie, Juanjuan, Zhang, Youcheng, Zheng, Xueyi, Zhu, Tianchen, Cai, Xiaoxia, Li, Peng, Chao, Xue, Cai, Mu-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854259/ https://www.ncbi.nlm.nih.gov/pubmed/35185894 http://dx.doi.org/10.3389/fimmu.2022.808101

Ejemplares similares

Body mass index, as a novel predictor of hepatocellular carcinoma patients treated with Anti-PD-1 immunotherapy
por: Chen, Jierong, et al.
Publicado: (2022)

Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors
por: Zhang, You-Cheng, et al.
Publicado: (2023)

Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma
por: Guan, Renguo, et al.
Publicado: (2022)

Potential Association of Reactive Oxygen Species With Male Sterility in Peach
por: Cai, Yaming, et al.
Publicado: (2021)

The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine
por: Yao, Yiyang, et al.
Publicado: (2023)

Surgical strategies for hepatocellular carcinoma located in the left lateral lobe: A propensity score‐matched and prognostic nomogram study
por: Zou, Jingwen, et al.
Publicado: (2021)

Recent Findings in the Posttranslational Modifications of PD-L1
por: Li, Shu-Man, et al.
Publicado: (2020)

Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity
por: Zhou, Jie, et al.
Publicado: (2022)

Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
por: Zhang, Xuanye, et al.
Publicado: (2019)

High‐Performance Li‐O(2) Batteries with Trilayered Pd/MnO(x)/Pd Nanomembranes
por: Lu, Xueyi, et al.
Publicado: (2015)

Advancement on Milk Fat Globule Membrane: Separation, Identification, and Functional Properties
por: Wang, Cong, et al.
Publicado: (2022)

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials
por: Zhao, Bai-Wei, et al.
Publicado: (2022)

Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications
por: Duan, Jin-Ling, et al.
Publicado: (2021)

Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma
por: Nie, Hanxiao, et al.
Publicado: (2021)

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2021)

Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway
por: Mei, Jie, et al.
Publicado: (2022)

Robust immunoscore model to predict the response to anti-PD1 therapy in melanoma
por: Nie, Run-Cong, et al.
Publicado: (2019)

Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma
por: Zhang, Tianchen, et al.
Publicado: (2022)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis
por: Chen, Xiao-Jiang, et al.
Publicado: (2023)

The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis
por: Nie, Run-Cong, et al.
Publicado: (2020)

Evaluation of Gait Variable Change over Time as Transtibial Amputees Adapt to a New Prosthesis Foot
por: Zhang, Xueyi, et al.
Publicado: (2019)

Measuring Balance Abilities of Transtibial Amputees Using Multiattribute Utility Theory
por: Zhang, Xueyi, et al.
Publicado: (2021)

Nivolumab plus ipilimumab versus pembrolizumab as chemotherapy‐free, first‐line treatment for PD‐L1‐positive non‐small cell lung cancer
por: Zhou, Yixin, et al.
Publicado: (2020)

BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022)

Bioinformatics Profiling of Five Immune-Related lncRNAs for a Prognostic Model of Hepatocellular Carcinoma
por: Wu, Fahong, et al.
Publicado: (2021)

Relationship between Intestinal Microflora and Hepatocellular Cancer Based on Gut-Liver Axis Theory
por: Li, Shipeng, et al.
Publicado: (2022)

Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
por: Wang, Yikai, et al.
Publicado: (2023)

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
por: Zheng, Yi, et al.
Publicado: (2019)

Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies
por: Jiang, Yawen, et al.
Publicado: (2022)

Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy
por: Zhang, Xinke, et al.
Publicado: (2022)

Patterning the consecutive Pd(3) to Pd(1) on Pd(2)Ga surface via temperature-promoted reactive metal-support interaction
por: Niu, Yiming, et al.
Publicado: (2022)

Revealing Prognostic and Immunotherapy-Sensitive Characteristics of a Novel Cuproptosis-Related LncRNA Model in Hepatocellular Carcinoma Patients by Genomic Analysis
por: Mao, Zhenzhen, et al.
Publicado: (2023)

Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma
por: Wang, Jialiang, et al.
Publicado: (2023)

Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective
por: Jia, Weili, et al.
Publicado: (2022)

A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma
por: Duan, Jin-Ling, et al.
Publicado: (2022)

The effect of anti-PD-1/PD-L1 antibodies combined with VEGF receptor tyrosine kinase inhibitors versus bevacizumab in unresectable hepatocellular carcinoma
por: Zeng, Hui, et al.
Publicado: (2023)

Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma
por: Jiang, Guangyi, et al.
Publicado: (2020)

The Role of Mitochondria-Derived Reactive Oxygen Species in Hyperthermia-Induced Platelet Apoptosis
por: Wang, Zhicheng, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sauqab4rpvtaabjmnm2p9pa099